AS
Ascletis Pharma Inc.
ASCLF · OTC
$1.20 -0.83% (-$0.01)
1M -7.69%
Market Cap ¥8.42B
P/E Ratio -
Div. Yield -
ROE 17.44%
Piotroski F-Score Weak
1/9Valuation
23 /100
Expensive P/B 4.35x
P/S 4,263.77x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 8.66%
Rev. growth 66.82%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 23,854.00%
Gross margin 842.70%
FCF margin 16,746.40%
Quality
0 /100
Poor ROA 16.96%
ROIC 24.25%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -2,949.78x
Debt/Equity 0.00x
Current ratio 15.05x
Stability
13 /100
Unstable EPS volatility 93.54%
Beta 0.39x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ASCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jinzi J. Wu
Employees
202
Headquarters
Hangzhou
Nadcházející události
30 BŘE
Earnings
Upcoming earnings report